StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Sigyn Therapeutics's revenue for the twelve months ending Sep 30, 2020 was $9.93K. For fiscal 2019 it was $143.32K, up 405.6% from the year before. The highest annual figure on record is $143.32K in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2019Dec 31, 2019$143.32K+405.6%
FY2018Dec 31, 2018$28.35K-26.2%
FY2017Dec 31, 2017$38.43K+31.6%
FY2015Dec 31, 2015$29.21K-32.3%
FY2014Dec 31, 2014$43.15K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$3.83K-88.1%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$756-98.2%
Q4 FY2019Dec 31, 2019$5.34K-94.1%
Q3 FY2019Sep 30, 2019$32.10K+456.3%
Q2 FY2019Jun 30, 2019$64.33K+177.9%
Q1 FY2019Mar 31, 2019$41.55K-83.8%
Q3 FY2018Sep 30, 2018$90.45K-79.1%
Q2 FY2018Jun 30, 2018$5.77K-97.9%
Q1 FY2018Mar 31, 2018$23.15K–
Q3 FY2017Sep 30, 2017$255.98K–
Q2 FY2017Jun 30, 2017$432.53K–
Q1 FY2017Mar 31, 2017$268.93K–
Q4 FY2015Dec 31, 2015$0–

More Sigyn Therapeutics figures

See a number that looks wrong?